Newsletter Articles

A scientific hub to keep you informed about our latest research and company updates.

Updates Straight To Your Inbox

Contact Our Research Experts

Longitudinal Efficacy Assessments of novel AEDs in the Stxbp1 +/- Epileptic Encephalopathy Model

Dec 7, 2023 | Neurology, Newsletter

Validated Delayed-type Hypersensitivity Assay in Wild Type or Humanized Mice

Nov 23, 2023 | Newsletter, Oncology

Validated Transdermal GFR Measurement in Kidney Disease Models

Nov 15, 2023 | Nephrology, Newsletter

Immunophenotyping to Evaluate Efficacy of Novel Immunotherapies

Nov 14, 2023 | Newsletter, Oncology

Auditory Event-Related Potentials EEG-Recording in Fmr1 KO mice

Nov 13, 2023 | Neurology, Newsletter

EEG Recording in the Epileptic Encephalopathy Model

Nov 13, 2023 | Neurology, Newsletter

Cognitive Readouts to Enhance the Efficacy Testing of Metabolic Compounds

Nov 13, 2023 | Neurology, Newsletter

Amyloid beta-induced neuroinflammation in Alzheimer’s disease models

Nov 13, 2023 | Neurology, Newsletter

Next Entries »

Be the first to know – get this news straight to your inbox

InnoSer provides a variety of validated in vitro and in vivo platforms for the efficient development of novel therapeutics. If you require additional information, feel free to reach out, and we will respond within a few days.

We provide a monthly update from our InnoSer labs containing scientific insights into our research services. To get news straight to your inbox please sign up here.

Discuss a project